Preeclampsia is a common disorder in pregnancy and may affect multiple maternal and foetal organ systems. Less common disorders with similar features may imitate preeclampsia though require different management strategies and with different prognostic implications for mother and baby. We present a case of a pregnant woman who developed severe hypertension and proteinuria in pregnancy. The early onset of these changes prompted investigation for causes other than preeclampsia, leading to a diagnosis of Cushing's syndrome due to stage III adrenocortical cancer. The changes in management strategy, the importance of a multidisciplinary approach to care, and the prognostic implications for the mother are discussed.
KeywordsHigh-risk pregnancy, endocrinology, cancer
CaseA 27-year-old gravida 2 para 1 at 26 weeks gestation was transferred from another hospital with a diagnosis of severe early onset preeclampsia. There was no significant past medical history, and the subjects' previous pregnancy was uneventful. The mother's booking blood pressure had been elevated at 135/88 mmHg at 13 weeks gestation, and she was commenced on antihypertensive drug therapy at 19 weeks gestation when her blood pressure was 160/105 mmHg. Despite escalating doses of labetalol and methyldopa, her blood pressure remained elevated, and she developed proteinuria quantified at 2 g in 24 h.On transfer, the mothers' body mass index was 34.6 g/m 2 , blood pressure was 180/105 mmHg, there was þþþþ proteinuria on dipstick testing and pitting oedema to the knees. Her serum potassium was 3.4 mmol/L and her blood sugar monitoring was unremarkable. Slow release nifedipine was added to maximal doses of labetalol and methyldopa.A procoagulant screen was normal, and urinary and plasma metanephrines and aldosterone:renin ratio were normal (aldosterone was 226 pmol/L and plasma renin activity was 28 mU/L), with an inactive urinary sediment. Twenty-four-hour urine-free cortisol was elevated at 1150 nmol/day using a local ultra high-performance liquid chromatography-tandem mass spectrometry assay 1 (normal5150), midnight serum cortisol was 923 nmol/L and adrenocorticotropic hormone (ACTH) was suppressed consistent with a diagnosis of Cushing's syndrome (CS) due to primary adrenal disease. The mother had impressive cutaneous striae, but no bruising, skin atrophy, proximal myopathy or other Cushingoid features. Magnetic resonance imaging demonstrated a 12 cm by 8 cm homogenous right adrenal mass with invasion of the inferior vena cava (IVC) consistent with adrenocortical cancer (Figure 1). The left adrenal gland was atrophic. Serum androstenedione was elevated at 120 nmol/L (normal512), dehydroepiandrosterone sulphate (DHEA-S) was 11 mmol/L (normal 1-11); no result for serum testosterone was obtained. There was no evidence of metastatic disease on computer axial tomography of the chest, and left ventricular function was normal on echocardiography. Ultrasound of the foetus revealed normal growth and placental Dopplers with an estimated foetal weight of 103...